![Anthony S. Chilton](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Anthony S. Chilton
No open positions remaining
Profile
Anthony S.
Chilton served as President, Chief Executive Officer & Director at Inotiv, Inc. from 2011 to 2012.
Prior to that, he was VP-Biopharmaceutical Development Division at Cardinal Health, Inc. and Vice President-PreClinical Development at Genmedica Therapeutics SL.
Chilton received his undergraduate degree from the University of East Anglia in 1981 and his doctorate from the University of Hertfordshire in 1993.
Former positions of Anthony S. Chilton
| Companies | Position | End |
|---|---|---|
| INOTIV, INC. | President | 2012-07-04 |
| CARDINAL HEALTH, INC. | Corporate Officer/Principal | - |
Genmedica Therapeutics SL
 Genmedica Therapeutics SL BiotechnologyHealth Technology Engages in the research and development of treatments for metabolic disorders | Corporate Officer/Principal | - |
Training of Anthony S. Chilton
Experiences
Positions held
Active
Inactive
Listed companies
Private companies
Connections
47
1st degree connections
5
1st degree companies
Male
Female
Members of the board
Executives
Linked companies
| Private companies | 5 |
|---|---|
Cardinal Health, Inc.
 Cardinal Health, Inc. Medical DistributorsDistribution Services Distributes pharmaceuticals and engages in manufacturing & sale of medical, surgical and laboratory supplies | Distribution Services |
Inotiv, Inc.
 Inotiv, Inc. Miscellaneous Commercial ServicesCommercial Services Provides drug discovery and development services | Commercial Services |
University of East Anglia
 University of East Anglia Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
University of Hertfordshire
 University of Hertfordshire Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Genmedica Therapeutics SL
Genmedica Therapeutics SL BiotechnologyHealth Technology Engages in the research and development of treatments for metabolic disorders | Health Technology |
- Stock Market
- Insiders
- Anthony S. Chilton
